Bioequivalence Study of Azacitidine for Injection in Myelodysplastic Syndrome (MDS) Patients
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Agnès-Paule GUERCI-BRESLER, MD
Service d'hématologie et de médecine interne-Hôpital de Brabois
Principal Investigator - Emmanuel GYAN, MD
Centre régional de cancérologie Henry-Kaplan Service d'Hématologie et thérapie cellulaire-Hôpital Bretonneau
Principal Investigator - Jean-Richard Eveillard, MD
CHU de Brest- Hôpital Morvan
Principal Investigator - Krimo Bouabdallah, MD
Hôpital Haut-Lévêque
Principal Investigator - Laurence LEGROS, MD
Hôpital Archet 1
Principal Investigator - Manjesh Lingamurthy, MD
Holy Cross Hospital
Principal Investigator - Mauricette MICHALLET, MD Professor
Hôpital Edouard Herriot
Principal Investigator - Misagh Karimi, MD
Wilshire Oncology Medical Group
Principal Investigator - Odile BEYNE-RAUZY, MD Professor
University Hospital, Toulouse
Principal Investigator - Pascal Cony-Makhoul, MD
CH Annecy
Principal Investigator - Pierre FENAUX, MD Professor
Service d'hématologie clinique- Hôpital Avicenne
Study Chair - Steven Hager, MD
California Cancer Associates
Principal Investigator - Veena Charu, MD
Pacific Cancer Medical Center Inc.
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Service D'Hématologie Clinique Hôpital Avicenne
Bobigny, France
- Chu de Brest- Hôpital Morvan
Brest, France
- Centre Hospitalier Lyon Sud
Lyon, France
- Hôpital Archet 1
Nice, France
- Hôpital Haut-Lévêque
Pessac, France
- Ch Annecy
Pringy, France
- Chu Purpan
Toulouse, France
- Centre Régional de Cancérologie Henry-Kaplan Service D'Hématologie Et Thérapie Cellulaire
Tours, France
- Service D'Hématologie Et de Médecine Interne Chu de Nancy Hôpital de Brabois
Vandœuvre-lès-Nancy, France
- Pacific Cancer Medical Center Inc.
Anaheim, California, United States
- Wilshire Oncology Medical Group
Corona, California, United States
- California Cancer Associates
Fresno, California, United States
- Holy Cross Hospital
Fort Lauderdale, Florida, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Apr 2011
- Primary completion
- 31 Dec 2012
- Completion
- 31 May 2013
- Last update posted
- 28 Jan 2015
- Registered enrollment
- 19
- Registry id
- NCT01152346
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.